isocitric acid has been researched along with Neoplasms in 7 studies
isocitric acid: RN given refers to unlabeled parent cpd
isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, T | 1 |
| Sato, K | 1 |
| Yamaguchi, M | 1 |
| Mitamura, K | 1 |
| Taga, A | 1 |
| Ye, S | 1 |
| Xu, P | 1 |
| Huang, M | 1 |
| Chen, X | 1 |
| Zeng, S | 1 |
| Wang, Q | 1 |
| Chen, J | 1 |
| Li, K | 1 |
| Gao, W | 1 |
| Liu, R | 1 |
| Liu, J | 1 |
| Shao, Y | 1 |
| Zhang, H | 1 |
| Xu, Y | 1 |
| Zhang, Q | 1 |
| Zhong, Z | 1 |
| Wei, Z | 1 |
| Wang, J | 1 |
| Hao, B | 1 |
| Huang, W | 1 |
| Liu, Q | 1 |
| Cheng, S | 1 |
| Larson, MG | 1 |
| McCabe, EL | 1 |
| Murabito, JM | 1 |
| Rhee, EP | 1 |
| Ho, JE | 1 |
| Jacques, PF | 1 |
| Ghorbani, A | 1 |
| Magnusson, M | 1 |
| Souza, AL | 1 |
| Deik, AA | 1 |
| Pierce, KA | 1 |
| Bullock, K | 1 |
| O'Donnell, CJ | 1 |
| Melander, O | 1 |
| Clish, CB | 1 |
| Vasan, RS | 1 |
| Gerszten, RE | 1 |
| Wang, TJ | 1 |
| Jiang, L | 1 |
| Shestov, AA | 1 |
| Swain, P | 1 |
| Yang, C | 1 |
| Parker, SJ | 1 |
| Wang, QA | 1 |
| Terada, LS | 1 |
| Adams, ND | 1 |
| McCabe, MT | 1 |
| Pietrak, B | 1 |
| Schmidt, S | 1 |
| Metallo, CM | 1 |
| Dranka, BP | 1 |
| Schwartz, B | 1 |
| DeBerardinis, RJ | 1 |
| Kawamura, A | 1 |
| Loenarz, C | 1 |
| Schofield, CJ | 1 |
| HAWTREY, AO | 1 |
| SILK, MH | 1 |
| Bhosale, P | 1 |
| Larson, AJ | 1 |
| Bernstein, PS | 1 |
7 other studies available for isocitric acid and Neoplasms
| Article | Year |
|---|---|
Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approach.
Topics: Cell Line, Tumor; Cells, Cultured; Chromatography, Liquid; Citric Acid Cycle; Energy Metabolism; Fum | 2021 |
The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cyclic N-Oxides; Female; Glutamine; Glycolysis; Heter | 2020 |
Distinct metabolomic signatures are associated with longevity in humans.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Female; Humans | 2015 |
Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
Topics: Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Citric Acid; Contact Inhibition; | 2016 |
Mutations to metabolic enzymes in cancer herald a need to unify genetics and biochemistry.
Topics: Citric Acid Cycle; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regul | 2011 |
Mitochondria of the Ehrlich ascites-tumour cell. 2. Diphosphopyridine nucleotide- and triphosphopyridine nucleotide-dependent oxidation of isocitrate.
Topics: Ascites; Citrates; Coenzymes; Isocitrates; Mitochondria; NAD; NADP; Neoplasms; Oxidation-Reduction | 1961 |
Factorial analysis of tricarboxylic acid cycle intermediates for optimization of zeaxanthin production from Flavobacterium multivorum.
Topics: beta Carotene; Bioreactors; Chromatography, High Pressure Liquid; Citric Acid Cycle; Culture Media; | 2004 |